Investment Summary |
|
|---|---|
| Date | 2017-12-12 |
| Target | Candee |
| Sector | Marketing |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 170 of 293 |
| Sector: Marketing M&A | 1 of 1 |
| Type: Venture M&A Deals | 149 of 266 |
| Country: Japan M&A | 13 of 25 |
| Year: 2017 M&A | 35 of 38 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-08 |
Denali Therapeutics
South San Francisco, California, United States Denali Therapeutics is a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. Denali Therapeutics was founded in 2013 and is based in South San Francisco, California. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-13 |
Lighthouse
London, United Kingdom Lighthouse is a provider of hospitality business intelligence, empowering hoteliers to deliver smarter revenue, distribution and marketing outcomes through its commercial platform. Lighthouse was founded in 2012 and is based in London, England. |
Buy | - |
